Analyst Research

Report Title Price
Arkema SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy
ValuEngine Detailed Valuation Report for ARKAY
Provider: ValuEngine, Inc.
$127.00
Buy
Wright Investors Service Comprehensive Report for Arkema Group
Provider: Wright Reports
$472.00
Buy
Arkema SA (AKE) - Financial and Strategic SWOT Analysis Review
Provider: GlobalData
$125.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Arkema SA Confirms FY 2012 EBITDA Guidance


Thursday, 8 Nov 2012 01:00am EST 

Arkema SA announced that it confirms its target to achieve an EBITDA close to EUR 1 billion in 2012. According to I/B/E/S Estimates, analysts on average are expecting the Company to report fiscal year EBITDA of EUR 1 billion. 

Latest Developments for Arkema SA

Latest Key Developments in Chemicals

Company Quote

Arkema SA
(AKE.PA)
79.11
0.33 +0.42%
22 May 2013